Ritonavir Tablet, Film Coated
Product Images NDC 65862-687

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ritonavir (NDC 65862-687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Ritonavir Fig1)

Chemical structure diagram presenting a formula calculation involving Body Surface Area (BSA) in square meters, height in centimeters, and weight in kilograms. It is not specifically related to the ritonavir drug product but depicts a medical calculation formula.*

FDA Label Image

Package Label Principal Display Panel (100 mg (30 Tablets Bottle))

Label for Ritonavir Tablets USP 100 mg film-coated tablets by Aurobindo Pharma Limited. The label states storage instructions, usage warnings, and dispensing notes for 30 tablets per container. Distributed by Aurobindo Pharma USA, Inc., it includes the NDC 65862-687-30 and specifies the product is made in India.*

FDA Label Image

Chemical Structure (Ritonavir Str)

Chemical structure of Ritonavir shown as a detailed molecular diagram representing its chemical bonds and constituent groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.